EVALUATED EFFECTIVENESS OF TRANSARTERIAL CHEMOEMBOLIZATION FOR HEPATOCELLULAR CARCINOMA
Main Article Content
Abstract
Objectives: We aimed to determine the effect of transarterial chemoembolization for hepatocellular carcinoma. Methods: A total of 71 patients with hepatocellular carcinoma treated with transarterial chemoembolization. Results: The mean age was 60.9 year. The single tumor accounted for 37 (52.1%). The main cause hepatocellular carcinoma was hepatitis B, 62 patients (87.3%). For overall survival rate of the 71 patients who underwent transarterial chemoembolization were 4.104 years. Conclusion: Transarterial chemoembolization treatment can improve overall survival in patients with hepatocellular carcinoma.
Article Details
Keywords
Transarterial chemoembolization, Hepatocellular carcinoma
References
2. Llovet, J.M., et al., Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet, 2002. 359(9319): p. 1734-9.
3. Lo, C.M., et al., Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology, 2002. 35(5): p. 1164-71.
4. Trevisani, F., et al., Etiologic factors and clinical presentation of hepatocellular carcinoma. Differences between cirrhotic and noncirrhotic Italian patients. Cancer, 1995. 75(9): p. 2220-32.